| |
| |
|
| Insider
Information: |
Morrison Jodie Pope |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
116,185 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$204,514 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
116,185 |
|
|
| Total
Value |
$204,514 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eledon Pharmaceuticals Ord Shs |
ELDN |
|
2016-01-08 |
57,566 |
|
0 |
Premium* |
|
|
Keryx Biopharmaceuticals Inc |
KERX |
Interim CEO, Director |
2018-12-12 |
0 |
2017-06-09 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2019-06-06 |
58,619 |
2018-12-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
58,619 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Interim CEO |
• • – |
2018-12-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(120,000) |
0 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2018-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
44,919 |
44,919 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Interim CEO |
• • – |
2018-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
120,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Interim CEO |
• • – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
110,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2017-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President and CEO |
• • – |
2016-01-08 |
4 |
OE |
$0.63 |
$32,449 |
D/D |
28,015 |
57,566 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President and CEO |
• • – |
2015-07-29 |
4 |
OE |
$0.63 |
$9,411 |
D/D |
10,564 |
29,551 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President and CEO |
• • – |
2015-07-29 |
4 |
AS |
$13.70 |
$7,727 |
D/D |
(564) |
19,551 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President and CEO |
• • – |
2015-07-28 |
4 |
AS |
$13.70 |
$164,400 |
D/D |
(12,000) |
19,551 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President and CEO |
• • – |
2015-07-28 |
4 |
OE |
$1.58 |
$18,960 |
D/D |
12,000 |
31,551 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President and CEO |
• • – |
2015-07-22 |
4 |
OE |
$0.63 |
$10,624 |
D/D |
10,000 |
19,551 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President and CEO |
• • – |
2015-06-29 |
4 |
AS |
$13.70 |
$109,600 |
D/D |
(8,000) |
9,551 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President and CEO |
• • – |
2015-06-29 |
4 |
OE |
$1.58 |
$12,640 |
D/D |
8,000 |
17,551 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President and CEO |
• • – |
2015-06-26 |
4 |
AS |
$13.83 |
$110,640 |
D/D |
(8,000) |
9,551 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President and CEO |
• • – |
2015-06-26 |
4 |
OE |
$1.58 |
$12,640 |
D/D |
8,000 |
17,551 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
President and CEOOfficer |
• • – |
2014-09-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,551 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
